Mitochondria-targeted peptide-engineered bimetallic nanozymes enable ferroptosis-sensitized cuproptosis for melanoma therapy.
- DOI
- 10.1016/j.mtbio.2026.103486
- Published
- 2026 Oct
- Container
- Materials today. Bio
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mtbio.2026.103486,
title = {Mitochondria-targeted peptide-engineered bimetallic nanozymes enable ferroptosis-sensitized cuproptosis for melanoma therapy.},
author = {Kong J and Cai M and Sun A and Zhao M and Li M and Wang X and Qiao J and Bao H and Zhao R and Xu B and Wang P and Tang Z},
year = {2026},
journal = {Materials today. Bio},
doi = {10.1016/j.mtbio.2026.103486},
url = {https://doi.org/10.1016/j.mtbio.2026.103486}
}RIS
TY - JOUR TI - Mitochondria-targeted peptide-engineered bimetallic nanozymes enable ferroptosis-sensitized cuproptosis for melanoma therapy. AU - Kong J AU - Cai M AU - Sun A AU - Zhao M AU - Li M AU - Wang X AU - Qiao J AU - Bao H AU - Zhao R AU - Xu B AU - Wang P AU - Tang Z PY - 2026 JO - Materials today. Bio DO - 10.1016/j.mtbio.2026.103486 UR - https://doi.org/10.1016/j.mtbio.2026.103486 ER -
APA
J, K., M, C., A, S., M, Z., M, L., X, W., J, Q., H, B., R, Z., B, X., P, W., & Z, T. (2026). Mitochondria-targeted peptide-engineered bimetallic nanozymes enable ferroptosis-sensitized cuproptosis for melanoma therapy.. Materials today. Bio. https://doi.org/10.1016/j.mtbio.2026.103486
Source records
- pubmed · retrieved 2026-11-10T11:13:59.399Z